Click to Share
 
 
  1. Latest News
  2. Submit Press Release
Filter News
Show All Results
News By Country
None Found
News By Tag
Diabetes Clinical Trial Remove


July 2015
Th We Tu Mo Su Sa Fr
2 1
June 2015
30 29 28 27 26

diabetes clinical trial Press Releases

  + XML/RSS  



By Achieve Clinical Research
A 26-week, multi-center, multinational, open-label, 2-arm parallel, randomized, treat-to-target trial in insulin naive subjects with Type 2 Diabetes. The total duration of the trial is approximately 29 weeks.
By Avail Clinical Research
This study is a Phase 1, Placebo-Controlled, Randomized Trial to Assess the Safety and Tolerability of a New Drug in Obese Hyperlipidemic Adults with or without Type 2 Diabetes
By Achieve Clinical Research
This trial is a 26-week, multi-center, multinational, open-label, 2-arm parallel, randomized, treat-to-target trial in insulin naïve subjects with T2DM inadequately controlled on a maximum tolerated dose or maximum dose according to label of GLP-1.
By Achieve Clinical Research
The primary objective of this 22 week study is to investigate the change in glycosylated hemoglobin (HbA1c) after receiving the new drug, as compared to those receiving a placebo.


Page updated every 10 minutes


Like PRLog?
9K2K1K
Click to Share